More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
Jiwon Oh, MD, PhD
Reducing the Burden of MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Immunologic Effects on Metabolic Syndrome and MS
Establishing Partnerships to Optimize Patient Outcomes
Optimizing MS Treatment Options
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Determining an MS Patient's Long-Term Prognosis
Current Landscape of MS Diagnosis/Prognosis
Emerging MRI Techniques in MS Patients
The Value of Biomarkers in MS Patients
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.